Literature DB >> 6229606

Inhibition of brain glycolysis by aluminum.

J C Lai, J P Blass.   

Abstract

Aluminum inhibited both the cytosolic and mitochondrial hexokinase activities in rat brain. The IC50 values were between 4 and 9 microM. Aluminum was effective at mildly acidic (pH 6.8) or slightly alkaline (pH 7.2-7.5) pH, in the presence of a physiological level of magnesium (0.5 mM). However, saturating (8 mM) magnesium antagonized the effect of aluminum on both forms of hexokinase activity. Other enzymes examined were considerably less sensitive to inhibition by aluminum. The IC50 of aluminum for phosphofructokinase was 1.8 mM and for lactate dehydrogenase 0.4 mM. At 10-600 microM, aluminum actually stimulated pyruvate kinase. Aluminum also inhibited lactate production by rat brain extracts: this effect was much more marked with glucose as substrate than with glucose-6-phosphate. However, the IC50 for inhibiting lactate production using glucose as substrate was 280 microM, higher than that required to inhibit hexokinase. This concentration of aluminum is comparable to those reportedly found in the brains of patients who had died with dialysis dementia and in the brains of some of the patients who had died with Alzheimer disease. Inhibition of carbohydrate utilization may be one of the mechanisms by which aluminum can act as a neurotoxin.

Entities:  

Mesh:

Substances:

Year:  1984        PMID: 6229606     DOI: 10.1111/j.1471-4159.1984.tb02697.x

Source DB:  PubMed          Journal:  J Neurochem        ISSN: 0022-3042            Impact factor:   5.372


  24 in total

1.  Hexokinase in astrocytes: kinetic and regulatory properties.

Authors:  J C Lai; K L Behar; B B Liang; L Hertz
Journal:  Metab Brain Dis       Date:  1999-06       Impact factor: 3.584

2.  Distribution of aluminum in different brain regions and body organs of rat.

Authors:  D Julka; R K Vasishta; K D Gill
Journal:  Biol Trace Elem Res       Date:  1996-05       Impact factor: 3.738

3.  Aluminum, altered transcription, and the pathogenesis of Alzheimer's disease.

Authors:  D R Crapper McLachlan; W J Lukiw; T P Kruck
Journal:  Environ Geochem Health       Date:  1990-03       Impact factor: 4.609

Review 4.  The role of environmental exposures in neurodegeneration and neurodegenerative diseases.

Authors:  Jason R Cannon; J Timothy Greenamyre
Journal:  Toxicol Sci       Date:  2011-09-13       Impact factor: 4.849

5.  Voltage gating in VDAC is markedly inhibited by micromolar quantities of aluminum.

Authors:  E T Dill; M J Holden; M Colombini
Journal:  J Membr Biol       Date:  1987       Impact factor: 1.843

6.  Differentiated neuroblastoma cells are more susceptible to aluminium toxicity than developing cells.

Authors:  M Roll; E Banin; H Meiri
Journal:  Arch Toxicol       Date:  1989       Impact factor: 5.153

7.  Evidence for centrophenoxine as a protective drug in aluminium induced behavioral and biochemical alteration in rat brain.

Authors:  Bimla Nehru; Punita Bhalla; Aarti Garg
Journal:  Mol Cell Biochem       Date:  2006-09-13       Impact factor: 3.396

8.  (13)C heteronuclear NMR studies of the interaction of cultured neurons and astrocytes and aluminum blockade of the preferential release of citrate from astrocytes.

Authors:  Shunsuke Meshitsuka; David A Aremu
Journal:  J Biol Inorg Chem       Date:  2007-11-15       Impact factor: 3.358

9.  Effects of aluminum sulphate and citric acid ingestion on lipid peroxidation and on activities of superoxide dismutase and catalase in cerebral hemisphere and liver of developing young chicks.

Authors:  C Swain; G B Chainy
Journal:  Mol Cell Biochem       Date:  1998-10       Impact factor: 3.396

10.  Differential lowering by manganese treatment of activities of glycolytic and tricarboxylic acid (TCA) cycle enzymes investigated in neuroblastoma and astrocytoma cells is associated with manganese-induced cell death.

Authors:  Gaurangi V Malthankar; Brenda K White; Alok Bhushan; Christopher K Daniels; Kenneth J Rodnick; James C K Lai
Journal:  Neurochem Res       Date:  2004-04       Impact factor: 3.996

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.